Document is current
Any future updates will be listed below
-
Authors
Abu-Rumeileh, Samir https://orcid.org/0000-0003-0631-8506
Otto, Markus
Bucher, Michael
Delank, Karl-Stefan
Carrubba, Carmelo
Ebersbach, Georg
Kassubek, Jan
Taute, Bettina-Maria
-
Funding
Funding for this research was provided by:
Medical Faculty of Martin-Luther-University Halle-Wittenberg (Clinician Scientist-Programm No. CS22/06)
Martin-Luther-Universität Halle-Wittenberg
- License Information
-
More Information
Article History
Received: 19 February 2025
Revised: 6 May 2025
Accepted: 7 May 2025
First Online: 21 May 2025
Declarations
:
: MO gave scientific advice to Axon, Biogen Idec, Fujirebio and Roche, all unrelated to the work presented in this paper. GE received honoraria for consultancy from AbbVie GmbH, Britannia Ltd., Canopy Medical GmbH, ESTEVE GmbH, Stada GmbH, BIAL GmbH, Desitin GmbH, Neuraxpharm GmbH, and Boehringer GmbH; he also received honoraria for lectures from AbbVie GmbH, BIAL GmbH, Cogitando GmbH, Desitin GmbH, ESTEVE GmbH, Licher GmbH, Milupa GmbH, Stada Pharma GmbH, and Zambon GmbH, and received royalties from Kohlhammer Verlag, Springer/Nature-Verlag, and Thieme Verlag. JK has received honoraria or consultation fees from AbbVie, Bial, Biogen, Desitin, Esteve, Novartis, STADA, UCB Pharma, and Zambon in the recent 3 years. The other authors report no competing interests.
: Written informed consent was collected from the patient for the inclusion of clinical data in a scientific publication, in accordance with the Declaration of Helsinki.
